Related Experiment Video
Updated: Aug 16, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Delphi-Based Consensus on Interstitial Lung Disease Screening in Patients with Connective Tissue Diseases (Croatian
Mislav Radić1,2, Srđan Novak3,4, Marko Barešić5,6
1Division of Rheumatology and Clinical Immunology, Centre of Excellence for Systemic Sclerosis Ministry of Health Republic of Croatia, University Hospital Centre Split, 21000 Split, Croatia.
This study developed a Croatian expert consensus for screening interstitial lung disease (ILD) in patients with connective tissue disease (CTD). The consensus provides algorithms for early detection, aiding multidisciplinary care.
Area of Science:
- Rheumatology
- Pulmonology
- Radiology
Background:
- Interstitial lung disease (ILD) is a severe manifestation of connective tissue disease (CTD).
- Early detection of CTD-ILD is crucial for patient prognosis.
- Current screening and diagnostic strategies require standardization.
Purpose of the Study:
- To establish a Croatian Delphi-based expert consensus for screening ILD in CTD patients.
- To develop evidence-based screening and monitoring algorithms for various CTDs.
- To facilitate early identification of at-risk individuals.
Main Methods:
- Systematic literature review on ILD risk factors, prevalence, diagnostics, and prognosis in specific CTDs.
- Delphi-based expert consensus development using online surveys.
- Formation of a multidisciplinary team (rheumatologists, pulmonologists, radiologists).
Main Results:
- Two consensus-based screening algorithms for CTD-ILD were developed.
- Recommended detection strategy includes pulmonary function testing and high-resolution computed tomography (HRCT) for specific CTDs (IIM, MCTD, SSc) and those with risk factors.
- Pulmonary function testing is recommended for newly diagnosed pSS, RA, and SLE.
Conclusions:
- The developed consensus provides a standardized approach to CTD-ILD screening in Croatia.
- Early identification and monitoring strategies are essential for managing this severe CTD manifestation.
- Multidisciplinary collaboration is key for optimal patient outcomes.
More Related Videos
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
04:10Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy
Published on: July 19, 2024
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Acute Coronary Syndrome III: Diagnostic Studies
Chronic Obstructive Pulmonary Disease-I: Introduction